Sofosbuvir/velpatasvir for 12weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis

October 2019

Author(s): Borgia SM, Dearden J, Yoshida EM, Shafran SD, Brown A, Ben-Ari Z, et al

Details: J Hepatol. 2019;71(4):660-5

NIHR Acknowledged: Yes

People
Photo Name Bio